Hims & Hers Health (HIMS) Cash & Equivalents (2019 - 2026)

Hims & Hers Health has disclosed Cash & Equivalents across 8 years of filings, most recently posting $222.3 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $222.3 million, down 18.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $222.3 million (down 18.8% YoY), and the FY2025 annual result was $228.6 million, up 3.64% from the prior year.
• Cash & Equivalents came in at $222.3 million for Q1 2026 at Hims & Hers Health, down from $228.6 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $1.1 billion in Q2 2025 to a low of $46.8 million in Q4 2022.
• The 5-year median for Cash & Equivalents is $105.2 million (2024), against an average of $193.7 million.
• Across the five-year window, Cash & Equivalents tumbled 48.64% in 2022 and surged 769.78% in 2025, its largest moves.
• Hims & Hers Health's Cash & Equivalents stood at $46.8 million in 2022, then jumped by 106.67% to $96.7 million in 2023, then jumped by 128.2% to $220.6 million in 2024, then grew by 3.64% to $228.6 million in 2025, then slipped by 2.78% to $222.3 million in 2026.
• The last three Cash & Equivalents figures came in at $222.3 million (Q1 2026), $228.6 million (Q4 2025), and $345.8 million (Q3 2025), per Business Quant data.